Mike Boken
Mike is a managing partner for Biocentric LLC, The Product Launch Experts. He was the team leader and strategist for the launch of Vyvanse (Shire's replacement product for Adderall XR) that now has gross sales upwards of $2.5B a year. He also played important roles in the launches of Prevnar, Intuniv, Flumist as well as numerous new indication launches during his pharmaceutical marketing career.
​
Throughout his 24 years of pharmaceutical industry success, Mike has proven his ability to deliver successful launch strategies across different disease states and product categories.
​
-
Team Leader - "VYVANSE - Small Pharma Marketing Team of the Year" Medical Marketing & Media magazine (January '10 Issue)
-
Recognized in "Top 45 Emerging Pharma Leaders Under 45 Years Old" Pharmaceutical Executive magazine (June '08 Issue)
-
Diverse experience includes US and EU marketing, small and large pharma employers, primary care and specialty products, and hospital products and medical devices
Jeff Roeseler
Jeff has over 15 years of pharmaceutical sales and senior leadership marketing experience. He has experience in Rare Disease, Orphan, Buy-and-Bill Biologic Devices, CNS, Respiratory, Gastroenterology, and Oncology products.
​
Jeff's Hands On Sales and Marketing Expertise Includes:
-
Forecasting
-
Sales Force Alignment
-
Pre-launch Market Development
-
Life-Cycle Management
-
BD Commercial Assessments
-
DTC Broadcast Advertising
-
Global Pricing and Market Access Strategies
-
Key Opinion Leader and Advocacy Development
